Home › Familial Amyloid Neuropathies › Massachusetts
Familial Amyloid Neuropathies clinical trials in Massachusetts
7 studies for Familial Amyloid Neuropathies are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810Ultrasound Therapy In Cardiac Amyloidosis
- Brigham and Women's Hospital, Boston
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Aug 21, 2026 · NCT04667494Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
- Brigham and Women's Hospital, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT07560306Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405US Benchmarking Clinical Study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Oct 20, 2025 · NCT07215715Exercise Training in Transthyretin Cardiac Amyloidosis
- Brigham and Women's Hospital, Boston
Recruiting
Ages 60 to 90 · All sexes · Updated Mar 18, 2025 · NCT05797857From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.